CONMED Corporation (NYSE:CNMD) — Stock Price
CONMED Corporation (NYSE:CNMD) is currently trading at $49.46 USD, up 0.69% today. Over the past 52 weeks, shares have ranged between $32.11 and $55.81. This page tracks CONMED Corporation's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of CONMED Corporation.
CONMED Corporation (CNMD) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CONMED Corporation's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
CONMED Corporation Income Statement — Revenue, Profit & Earnings by Year
CONMED Corporation's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $1.37 Billion | $1.31 Billion | $1.24 Billion | $1.05 Billion | $1.01 Billion |
| Cost of Revenue | $649.12 Million | $573.98 Million | $568.50 Million | $474.23 Million | $442.60 Million |
| Gross Profit | $725.38 Million | $733.03 Million | $676.25 Million | $571.25 Million | $568.04 Million |
| Research & Development | $55.88 Million | $54.43 Million | $52.60 Million | $47.15 Million | $43.56 Million |
| SG&A | $591.97 Million | $453.99 Million | $505.82 Million | $454.04 Million | $414.75 Million |
| Total Operating Expenses | $584.24 Million | $532.71 Million | $555.64 Million | $501.19 Million | $458.32 Million |
| Operating Income | $141.13 Million | $200.33 Million | $120.60 Million | $70.05 Million | $109.72 Million |
| EBITDA | $193.47 Million | $272.18 Million | $192.48 Million | $7.80 Million | $179.33 Million |
| EBIT | $141.13 Million | $200.33 Million | $120.60 Million | $-41.96 Million | $108.59 Million |
| Interest Expense | $31.09 Million | $37.30 Million | $39.77 Million | $28.91 Million | $35.48 Million |
| Income Before Tax | $71.12 Million | $163.03 Million | $80.83 Million | $-70.86 Million | $73.11 Million |
| Income Tax Expense | $24.06 Million | $30.61 Million | $16.37 Million | $9.72 Million | $10.56 Million |
| Net Income | $47.05 Million | $132.42 Million | $64.46 Million | $-80.58 Million | $62.54 Million |
CONMED Corporation Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CONMED Corporation's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $2.33 Billion | $2.31 Billion | $2.30 Billion | $2.30 Billion | $1.77 Billion |
| Total Current Assets | $672.86 Million | $640.01 Million | $615.65 Million | $581.23 Million | $460.12 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $247.83 Million | $237.73 Million | $242.28 Million | $191.34 Million | $183.88 Million |
| Inventory | $355.54 Million | $346.72 Million | $318.32 Million | $332.32 Million | $231.64 Million |
| Property, Plant & Equipment | — | — | — | $115.61 Million | $108.86 Million |
| Goodwill | $807.01 Million | $805.36 Million | $806.84 Million | $815.43 Million | $617.53 Million |
| Total Liabilities | $1.29 Billion | $1.34 Billion | $1.47 Billion | $1.55 Billion | $980.58 Million |
| Total Current Liabilities | $315.04 Million | $278.13 Million | $310.73 Million | $296.55 Million | $196.65 Million |
| Long-term Debt | $834.23 Million | $905.07 Million | $973.14 Million | $985.08 Million | $672.41 Million |
| Net Debt | $794.12 Million | $881.32 Million | $966.96 Million | $1.03 Billion | $663.81 Million |
| Total Stockholder Equity | $1.03 Billion | $962.68 Million | $834.22 Million | $745.54 Million | $785.43 Million |
| Retained Earnings | $588.77 Million | $560.28 Million | $452.53 Million | $412.63 Million | $496.61 Million |
CONMED Corporation Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CONMED Corporation generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $170.69 Million | $166.97 Million | $125.35 Million | $33.37 Million | $111.77 Million |
| Capital Expenditures | $19.81 Million | $13.08 Million | $19.03 Million | $21.79 Million | $14.87 Million |
| Free Cash Flow | $150.88 Million | $153.88 Million | $106.32 Million | $11.58 Million | $96.90 Million |
| Investing Cash Flow | $-20.96 Million | $-13.08 Million | $-20.03 Million | $-249.53 Million | $-14.87 Million |
| Financing Cash Flow | $-135.82 Million | $-151.00 Million | $-110.43 Million | $225.00 Million | $-101.55 Million |
| Dividends Paid | $-24.75 Million | $-24.65 Million | $-24.50 Million | $23.96 Million | $23.26 Million |
| Stock-Based Compensation | $28.32 Million | $25.56 Million | $24.26 Million | $21.73 Million | $16.34 Million |
| Depreciation | $74.28 Million | $51.30 Million | $51.40 Million | $69.52 Million | $70.74 Million |
| Change in Cash | $16.36 Million | $163.00K | $-4.65 Million | $8.10 Million | $-6.51 Million |
CONMED Corporation Earnings History — EPS Actual vs. Analyst Estimates
Track CONMED Corporation's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 0.89 | 0.82 | +8.79% |
| Jan 29, 2026 | 1.43 | 1.33 | +7.52% |
| Oct 29, 2025 | 1.08 | 1.05 | +2.86% |
| Jul 30, 2025 | 0.69 | 0.95 | -27.37% |
| Apr 30, 2025 | 0.95 | 0.81 | +17.28% |
| Feb 05, 2025 | 1.34 | 1.20 | +11.67% |
| Oct 30, 2024 | 1.05 | 1.00 | +5.00% |
| Jul 31, 2024 | 0.98 | 0.91 | +7.69% |